R. Lorenz

684 total citations
31 papers, 361 citations indexed

About

R. Lorenz is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, R. Lorenz has authored 31 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Cancer Research. Recurrent topics in R. Lorenz's work include Effects of Radiation Exposure (5 papers), Carcinogens and Genotoxicity Assessment (5 papers) and DNA Repair Mechanisms (4 papers). R. Lorenz is often cited by papers focused on Effects of Radiation Exposure (5 papers), Carcinogens and Genotoxicity Assessment (5 papers) and DNA Repair Mechanisms (4 papers). R. Lorenz collaborates with scholars based in Germany, United States and Switzerland. R. Lorenz's co-authors include Klaus Hempel, K. Hempel, Joseph Claßen, David Weise, Andreas Schirbel, Karlheinz Reiners, Matthias Kieslich, Vladimir Vukićević, Gerhard Marquardt and Helga Stopper and has published in prestigious journals such as Environmental Health Perspectives, Annals of Oncology and Movement Disorders.

In The Last Decade

R. Lorenz

30 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Lorenz Germany 11 121 100 83 68 59 31 361
I Suzuki Japan 10 127 1.0× 35 0.3× 64 0.8× 6 0.1× 28 0.5× 24 340
Lijin Wang China 10 97 0.8× 29 0.3× 56 0.7× 24 0.4× 20 0.3× 23 257
Nobuyuki Umegae Japan 8 92 0.8× 100 1.0× 21 0.3× 14 0.2× 36 0.6× 9 318
Geneviève Beaurain France 8 93 0.8× 44 0.4× 30 0.4× 11 0.2× 28 0.5× 9 349
B Ringertz Sweden 12 81 0.7× 25 0.3× 12 0.1× 24 0.4× 46 0.8× 20 417
Xinyue Tang China 11 95 0.8× 19 0.2× 32 0.4× 21 0.3× 11 0.2× 29 309
Mark McCormack Ireland 11 207 1.7× 107 1.1× 44 0.5× 6 0.1× 37 0.6× 22 545
R Bílek Czechia 11 69 0.6× 18 0.2× 20 0.2× 29 0.4× 37 0.6× 36 326
Youjin Wang United States 13 192 1.6× 50 0.5× 37 0.4× 5 0.1× 93 1.6× 45 429
Selçuk Daşdemir Türkiye 12 175 1.4× 18 0.2× 12 0.1× 27 0.4× 22 0.4× 24 380

Countries citing papers authored by R. Lorenz

Since Specialization
Citations

This map shows the geographic impact of R. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lorenz more than expected).

Fields of papers citing papers by R. Lorenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lorenz. The network helps show where R. Lorenz may publish in the future.

Co-authorship network of co-authors of R. Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of R. Lorenz. A scholar is included among the top collaborators of R. Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Lorenz. R. Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loibl, S., Michael Untch, Jens Huober, et al.. (2025). 292MO Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Long-term analysis from the GeparNuevo trial. Annals of Oncology. 36. S303–S304. 1 indexed citations
2.
Romanos, Marcel, Susanne Walitza, Manfred Gerlach, et al.. (2022). Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Frontiers in Psychiatry. 13. 804730–804730. 4 indexed citations
3.
Trapp, Elisabeth, Brigitte Rack, Lothar Häberle, et al.. (2016). Detection of circulating tumor cells during long-term follow-up of high-risk breast cancer patients indicates poor prognosis – results of the adjuvant SUCCESS A trial. Geburtshilfe und Frauenheilkunde. 76(10). 1 indexed citations
4.
Isaias, Ioannis U., Joachim Brumberg, Kelly Cosgrove, et al.. (2014). Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease. Frontiers in Aging Neuroscience. 6. 213–213. 23 indexed citations
5.
Lorenz, R., et al.. (2010). Stationäre nuklearmedizinische Therapie in Deutschland – Analyse der strukturierten Qualitätsberichte 2004 bis 2008. Nuklearmedizin - NuclearMedicine. 49(2). 49–57. 10 indexed citations
6.
Dietlein, Markus, et al.. (2010). Nuclear medical inpatient treatment in Germany. Nuklearmedizin - NuclearMedicine. 49(2). 49–57. 10 indexed citations
7.
Weise, David, et al.. (2009). Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Movement Disorders. 24(11). 1669–1675. 54 indexed citations
8.
Schmidt, Folkhard, R. Lorenz, K. Loeschke, et al.. (2009). Factors influencing long‐term changes in mental health after interferon‐alpha treatment of chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 30(10). 1049–1059. 13 indexed citations
9.
10.
Grawé, Jan, Johannes Biko, R. Lorenz, et al.. (2005). Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 583(1). 12–25. 36 indexed citations
11.
Biko, Johannes, et al.. (2004). Dose response for T-cell receptor (TCR) mutants in patients repeatedly treated with for thyroid cancer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 548(1-2). 27–33. 7 indexed citations
12.
Hempel, Klaus, et al.. (2003). High gradient magnetic cell sorting and internal standardisation substantially improve the assay for somatic mutations at the glycophorin A (GPA) locus. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 525(1-2). 29–42. 2 indexed citations
13.
Marquardt, Gerhard, et al.. (2001). Neurological and mental outcome after severe head injury in childhood: a long-term follow-up of 318 children. Disability and Rehabilitation. 23(15). 665–669. 32 indexed citations
14.
Bassukas, Ioannis D., et al.. (1996). Age dependent selection against HPRT deficient T lymphocytes in the HPRT± heterozygous mouse. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 351(1). 67–77. 24 indexed citations
15.
Wixler, Viktor, et al.. (1995). Mutant Frequency at the H-2K Class 1 and HPRT Genes in T Lymphocytes from the X-ray-exposed Mouse. International Journal of Radiation Biology. 67(4). 421–430. 9 indexed citations
16.
Wixler, Viktor, et al.. (1994). Isolation and quantification of class 1 MHC gene mutants in mouse T cells by immunoselection with a magnetic cell sorter (MACS). Journal of Immunological Methods. 171(1). 121–130. 5 indexed citations
17.
Lorenz, R., et al.. (1993). Normal and reverse dose-rate effect for the induction of mutants in somatic cells by ionizing radiation. Toxicology Letters. 67(1-3). 353–363. 13 indexed citations
18.
Lorenz, R., et al.. (1990). Quantification of thioguanine-resistant lymphocytes from mice irradiated in vivo.. Environmental Health Perspectives. 88. 129–132. 7 indexed citations
19.
Wolters, U, et al.. (1990). Milzzysten: indikation zur operation und operatives vorgehen@@@Splenic cysts: indication to operate and operative procedure. Langenbeck s Archives of Surgery. 375(4). 2 indexed citations
20.
Lorenz, R., et al.. (1988). Visuelle Störungen durch Diphenylhydantoin: Klinische und elektroophthalmologische Befunde*. Klinische Monatsblätter für Augenheilkunde. 192(3). 244–247. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I Suzuki Breakdown of academic impact, for papers by Lijin Wang Breakdown of academic impact, for papers by Nobuyuki Umegae Breakdown of academic impact, for papers by Geneviève Beaurain Breakdown of academic impact, for papers by B Ringertz Breakdown of academic impact, for papers by Xinyue Tang Breakdown of academic impact, for papers by Mark McCormack Breakdown of academic impact, for papers by R Bílek Breakdown of academic impact, for papers by Youjin Wang Breakdown of academic impact, for papers by Selçuk Daşdemir
Rankless by CCL
2026